◆英語タイトル：HanAll Biopharma Co Ltd (009420) - Financial and Strategic SWOT Analysis Review
◆産業分野：Pharmaceuticals and Healthcare
HanAll Biopharma Co Ltd (HanAll), formerly HanAll Pharmaceutical Co Ltd, is a developer of generic and specialty drugs for treatment of diseases related to digestive, endocrine, musculoskeletal and urinary system. The company’s pipeline products include HL036, a drug being developed for treating dry eye diseases; HL189 against non-infectious uveitis; IM156 targeting cancers; and HL190 to treat wet age-related macular degeneration. It also sells drugs for treating digestive dysfunction, osteoporosis, liver dysfunction, hepatic coma, metabolic disorders caused due to hypocalcemia, tetania, bone pain and bone lesions. HanAll also conducts research for developing drugs in the therapeutic areas of autoimmune, eye diseases and immuno oncology indications. The company works in partnership with global pharmaceutical companies and academic institutions for advancing its pipeline products. It has operations in South Korea and the US. HanAll is headquartered in Seoul, South Korea
HanAll Biopharma Co Ltd Key Recent Developments
Jan 19,2021: Hanall Biopharma, net profit in 2020 increased by 14% from the previous year to KRW 21.9 billion
Oct 29,2020: Hanall Biopharma achieved sales of 22.1 billion won, operating profit of 1 billion, and net profit of 3.7 billion in the third quarter
Jul 29,2020: Hanol Biopharma achieved 22.6 billion won in sales in 2Q and 1.6 billion in operating profit
This comprehensive SWOT profile of HanAll Biopharma Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of HanAll Biopharma Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
HanAll Biopharma Co Ltd – Key Information
HanAll Biopharma Co Ltd – Overview
HanAll Biopharma Co Ltd – Key Employees
HanAll Biopharma Co Ltd – Key Employee Biographies
HanAll Biopharma Co Ltd – Key Operational Heads
HanAll Biopharma Co Ltd – Major Products and Services
HanAll Biopharma Co Ltd – History
HanAll Biopharma Co Ltd – Company Statement
HanAll Biopharma Co Ltd – Locations And Subsidiaries
HanAll Biopharma Co Ltd
Other Locations & Subsidiaries
Section 2 – Company Analysis
HanAll Biopharma Co Ltd – Business Description
HanAll Biopharma Co Ltd – Corporate Strategy
HanAll Biopharma Co Ltd – SWOT Analysis
SWOT Analysis – Overview
HanAll Biopharma Co Ltd – Strengths
HanAll Biopharma Co Ltd – Weaknesses
HanAll Biopharma Co Ltd – Opportunities
HanAll Biopharma Co Ltd – Threats
HanAll Biopharma Co Ltd – Key Competitors
Section 3 – Company Financial Performance Charts
HanAll Biopharma Co Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
HanAll Biopharma Co Ltd, Key Information
HanAll Biopharma Co Ltd, Key Ratios
HanAll Biopharma Co Ltd, Share Data
HanAll Biopharma Co Ltd, Major Products and Services
HanAll Biopharma Co Ltd, History
HanAll Biopharma Co Ltd, Key Employees
HanAll Biopharma Co Ltd, Key Employee Biographies
HanAll Biopharma Co Ltd, Key Operational Heads
HanAll Biopharma Co Ltd, Other Locations
HanAll Biopharma Co Ltd, Subsidiaries
HanAll Biopharma Co Ltd, Key Competitors
HanAll Biopharma Co Ltd, SWOT Analysis
HanAll Biopharma Co Ltd, Ratios based on current share price
HanAll Biopharma Co Ltd, Annual Ratios
HanAll Biopharma Co Ltd, Interim Ratios
Capital Market Ratios
| ★海外企業調査レポート[HanAll Biopharma Co Ltd (009420)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら